scispace - formally typeset
C

Chul Woo Ahn

Researcher at Yonsei University

Publications -  335
Citations -  9384

Chul Woo Ahn is an academic researcher from Yonsei University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 42, co-authored 302 publications receiving 8033 citations. Previous affiliations of Chul Woo Ahn include Ewha Womans University & Kwandong University.

Papers
More filters
Journal ArticleDOI

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, +798 more
- 27 Oct 2018 - 
TL;DR: In patients with type 2 diabetes and cardiovascular disease, albiglutide was superior to placebo with respect to major adverse cardiovascular events, and evidence-based glucagon-like peptide 1 receptor agonists should be considered as part of a comprehensive strategy to reduce the risk of cardiovascular events.
Journal ArticleDOI

Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults

TL;DR: Nonalcoholic fatty liver disease is closely associated with metabolic disorders, even in nonobese, nondiabetic subjects, and can be considered an early predictor of metabolic Disorders, particularly in the normal-weight population.
Journal ArticleDOI

Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound.

TL;DR: The data indicate that rheumatoid arthritis patients have an ultrasonic marker of early atherosclerosis consistent with an increased risk for Atherosclerosis.
Journal ArticleDOI

Preventative Effects of Rosiglitazone on Restenosis After Coronary Stent Implantation in Patients With Type 2 Diabetes

TL;DR: It is demonstrated that treatment with rosiglitazone significantly reduces in-stent restenosis in diabetic patients with CAD who underwent coronary stent implantation.